ImPact Biotech Presents Updated Data from Phase 3 ENLIGHTED Trial of Padeliporfin VTP in LG-UTUC at AUA 2026
– Complete response (CR) observed in 70% (50/72) of evaluable patients with…
Imviva Biotech Presents Data Demonstrating Durable Clinical Responses from Ongoing Phase 1/2 Study of CTA313 in Systemic Lupus Erythematosus at ASGCT 2026
100% of patients treated with CTA313 achieved an SRI-4 response, with half…
Avance Clinical Receives Frost & Sullivan’s 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership
The company is recognized for its innovation, scientific expertise, and customer-centric clinical…
GenScript Sets New Benchmark for Responsible Biotech Leadership with 2025 ESG Report
Advancing Climate Action, Governance Excellence, and Global Scientific ImpactPISCATAWAY, N.J., April 14,…
Tvardi Therapeutics to Participate in the Raymond James Biotech Innovation Symposium
April 02, 2026 08:00 ET | Source: Tvardi Therapeutics HOUSTON, April 02,…
Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer
BASEL, Switzerland, March 23, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage preclinical…
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
Group PerformanceRevenue: US$959.5 million, +61.4% year-on-yearGross profit: US$553.2 million, +103.3% year-on-yearAdjusted net…
GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub
Strategic investment reinforces Europe as a core pillar of GenScript's global R&D and production…
Commit Biologics appoints serial biotech founder as new CEO to take complement-powered immune engagers into the clinic
Dr. Thomas L. F. Montgomery Andresen joins from T-Cypher BioFollows breakthrough non-human…
NKGen Biotech to Present Integrated Phase 1 Clinical and Biomarker Analyses for Troculeucel in Alzheimers Disease at AD/PD 2026
March 10, 2026 08:05 ET | Source: NKGen Biotech, Inc. SANTA ANA,…
